Point72 Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Point72 Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$352K	Sell	148,358 -240,888	-62%	-$834K	﹤0.01%	3302
2025 Q4	$2.02M	Buy	+389,246	New	+$1.89M	﹤0.01%	2471
2023 Q4	–	Sell	-425,000	Closed	-$1.35M	–	2642
2023 Q3	$1.35M	Buy	425,000 +419,096	+7,099%	+$1.33M	﹤0.01%	1240
2023 Q2	$19.6K	Sell	5,904 -62,427	-91%	-$184K	﹤0.01%	1789
2023 Q1	$146K	Buy	+68,331	New	+$169K	﹤0.01%	1561

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Point72 Asset Management's ORGO Position: Q1 2026 in Review

Point72 Asset Management reduced its Organogenesis Holdings (ORGO) stake by 62% in Q1 2026, selling an estimated $834K and leaving 148,358 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #3302.

Point72 Asset Management first reported a position in ORGO in Q1 2023 and has held it in 5 quarters since. The position peaked at $2.02M in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Point72 Asset Management held 148,358 shares of Organogenesis Holdings worth $352K as of Q1 2026.
Point72 Asset Management sold 240,888 Organogenesis Holdings shares in Q1 2026, an estimated $834K.
Organogenesis Holdings made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3302 holding.
Point72 Asset Management first reported a position in Organogenesis Holdings in Q1 2023 and has held it in 5 quarters since.
Point72 Asset Management's Organogenesis Holdings position peaked at $2.02M in Q4 2025.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.